Seroconversion after influenza vaccination in patients with lung cancer

There are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response r...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, H, Petrie, K, Berrisford, C, Charlett, A, Thatcher, N, Zambon, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362985/
https://www.ncbi.nlm.nih.gov/pubmed/10389999
http://dx.doi.org/10.1038/sj.bjc.6690342
_version_ 1782153590707585024
author Anderson, H
Petrie, K
Berrisford, C
Charlett, A
Thatcher, N
Zambon, M
author_facet Anderson, H
Petrie, K
Berrisford, C
Charlett, A
Thatcher, N
Zambon, M
author_sort Anderson, H
collection PubMed
description There are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers. © 1999 Cancer Research Campaign
format Text
id pubmed-2362985
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23629852009-09-10 Seroconversion after influenza vaccination in patients with lung cancer Anderson, H Petrie, K Berrisford, C Charlett, A Thatcher, N Zambon, M Br J Cancer Regular Article There are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers. © 1999 Cancer Research Campaign Nature Publishing Group 1999-04 /pmc/articles/PMC2362985/ /pubmed/10389999 http://dx.doi.org/10.1038/sj.bjc.6690342 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Anderson, H
Petrie, K
Berrisford, C
Charlett, A
Thatcher, N
Zambon, M
Seroconversion after influenza vaccination in patients with lung cancer
title Seroconversion after influenza vaccination in patients with lung cancer
title_full Seroconversion after influenza vaccination in patients with lung cancer
title_fullStr Seroconversion after influenza vaccination in patients with lung cancer
title_full_unstemmed Seroconversion after influenza vaccination in patients with lung cancer
title_short Seroconversion after influenza vaccination in patients with lung cancer
title_sort seroconversion after influenza vaccination in patients with lung cancer
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362985/
https://www.ncbi.nlm.nih.gov/pubmed/10389999
http://dx.doi.org/10.1038/sj.bjc.6690342
work_keys_str_mv AT andersonh seroconversionafterinfluenzavaccinationinpatientswithlungcancer
AT petriek seroconversionafterinfluenzavaccinationinpatientswithlungcancer
AT berrisfordc seroconversionafterinfluenzavaccinationinpatientswithlungcancer
AT charletta seroconversionafterinfluenzavaccinationinpatientswithlungcancer
AT thatchern seroconversionafterinfluenzavaccinationinpatientswithlungcancer
AT zambonm seroconversionafterinfluenzavaccinationinpatientswithlungcancer

Ejemplares similares